Novonesis (Novozymes) B (NSISBC.XD)

DKK 410.0

(-0.89%)

Net Income Summary of Novonesis (Novozymes) B

  • Novonesis (Novozymes) B's latest annual net income in 2023 was 3.02 Billion DKK , down -17.74% from previous year.
  • Novonesis (Novozymes) B's latest quarterly net income in 2024 Q2 was 238.31 Million DKK , down -0.01% from previous quarter.
  • Novonesis (Novozymes) B reported an annual net income of 3.67 Billion DKK in 2022, up 16.85% from previous year.
  • Novonesis (Novozymes) B reported an annual net income of 3.14 Billion DKK in 2021, up 11.36% from previous year.
  • Novonesis (Novozymes) B reported a quarterly net income of 238.31 Million DKK for 2024 Q2, down -0.01% from previous quarter.
  • Novonesis (Novozymes) B reported a quarterly net income of 606 Million DKK for 2023 Q2, down -22.7% from previous quarter.

Annual Net Income Chart of Novonesis (Novozymes) B (2023 - 2019)

Historical Annual Net Income of Novonesis (Novozymes) B (2023 - 2019)

Year Net Income Net Income Growth
2023 3.02 Billion DKK -17.74%
2022 3.67 Billion DKK 16.85%
2021 3.14 Billion DKK 11.36%
2020 2.82 Billion DKK -10.43%
2019 3.15 Billion DKK 0.0%

Peer Net Income Comparison of Novonesis (Novozymes) B

Name Net Income Net Income Difference